UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003076 |
|---|---|
| Receipt number | R000003667 |
| Scientific Title | Phase II study to evaluate the safety and the efficacy of CBD (Bortezomib, Cyclophosphamide, Dexamethasone) regimen for the patients with relapsed and/or refractory multiple myeloma |
| Date of disclosure of the study information | 2010/02/01 |
| Last modified on | 2012/02/14 14:09:39 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/01/22 14:48:42 | ||
| 2 | Update | 2012/02/14 14:09:39 | Name of person sending information Organization Division name Address Organization Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
